Promoter methylation of BRCA1 in the prognosis of breast cancer: A meta-analysis

Breast Cancer Research and Treatment

Volumn 142, Issue 3, 2013, Pages 619-627

  Wu, Liang ^a   Wang, Fengliang ^a   Xu, Ruobing ^a   Zhang, Simin ^a   Peng, Xianzhen ^a   Feng, Yan ^a   Wang, Jianming ^a   Lu, Cheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

BRCA1; Breast cancer; Meta analysis; Methylation; Prognosis; Survival

Indexed keywords

TUMOR MARKER;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PROGNOSIS; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE MARKER; DNA METHYLATION; EPIGENETICS; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMATIC REVIEW; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; DNA METHYLATION; FEMALE; GENES, BRCA1; HUMANS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; PUBLICATION BIAS;

EID: 84890309501     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2774-9     Document Type: Article

References (46)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer J 127(12):2893-2917. doi: 10.1002/ijc.25516
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90. doi: 10.3322/caac.20107
3. Mukherjee A, Rakha EA (2012) Integrating breast cancer genetics into clinical practice. Womens Health (Lond Engl) 8(1):99-112. doi: 10.2217/whe.11.81
4. Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 12(4):207. doi: 10.1186/bcr2607
5. Baylin SB, Belinsky SA, Herman JG (2000) Aberrant methylation of gene promoters in cancer - concepts, misconcepts, and promise. J Natl Cancer Inst 92(18):1460-1461
6. Jones PA, Laird PW (1999) Cancer epigenetics comes of age. Nat Genet 21(2):163-167. doi: 10.1038/5947
7. Toh Y, Egashira A, Yamamoto M (2013) Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma. Gen Thorac Cardiovasc Surg 61(5):262-269. doi: 10.1007/s11748-013-0235-3
8. Fang F, Turcan S, Rimner A, Kaufman A, Giri D, Morris LG, Shen R, Seshan V, Mo Q, Heguy A, Baylin SB, Ahuja N, Viale A, Massague J, Norton L, Vahdat LT, Moynahan ME, Chan TA (2011) Breast cancer methylomes establish an epigenomic foundation for metastasis. Sci Transl Med 3 (75):75ra25. doi: 10.1126/scitranslmed.3001875
9. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128(4):683-692. doi: 10.1016/j.cell.2007.01.029
10. Cheol Kim D, Thorat MA, Lee MR, Cho SH, Vasiljevic N, Scibior-Bentkowska D, Wu K, Ahmad AS, Duffy S, Cuzick JM, Lorincz AT (2012) Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes. Cancer Biomark 11(2-3):75-88. doi: 10.3233/CBM-2012-0266
11. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(4988):1684-1689
12. Ralhan R, Kaur J, Kreienberg R, Wiesmuller L (2007) Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett 248(1):1-17. doi: 10.1016/j.canlet.2006.06.004
13. Chen Y, Zhou J, Xu Y, Li Z, Wen X, Yao L, Xie Y, Deng D (2009) BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer. Cancer Sci 100(9):1663-1667. doi: 10.1111/j.1349-7006. 2009.01225.x
14. Xu X, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT, Garbowski G, Teitelbaum SL, Neugut AI, Santella RM, Chen J (2009) BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat 115(2):397-404. doi: 10.1007/s10549-008-0075-5
15. Khan SI, Aumsuwan P, Khan IA, Walker LA, Dasmahapatra AK (2012) Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chem Res Toxicol 25(1):61-73. doi: 10.1021/tx200378c
16. Hsu NC, Huang YF, Yokoyama KK, Chu PY, Chen FM, Hou MF (2013) Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer. PLoS One 8(2):e56256. doi: 10.1371/journal.pone. 0056256
17. Van De Voorde L, Speeckaert R, Van Gestel D, Bracke M, De Neve W, Delanghe J, Speeckaert M (2012) DNA methylation-based biomarkers in serum of patients with breast cancer. Mutat Res 751(2):304-325. doi: 10.1016/j.mrrev. 2012.06.001
18. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. doi: 10.1371/journal.pmed.1000097
19. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16. doi: 10.1186/1745-6215-8-16
20. DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15(12):1237-1248; discussion 1249-1252. doi: 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560. doi: 10.1136/bmj.327. 7414.557
22. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
23. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188
24. Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H, Moons KG (2009) More than numbers: the power of graphs in meta-analysis. Am J Epidemiol 169(2):249-255. doi: 10.1093/aje/kwn340
25. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-826
26. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629-634
27. Xu Y, Diao L, Chen Y, Liu Y, Wang C, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Deng D, Narod SA, Xie Y (2013) Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy. Ann Oncol 24(6):1498-1505. doi: 10.1093/annonc/mdt011
28. Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R (2010) Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci 87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001
29. Sharma G, Mirza S, Yang YH, Parshad R, Hazrah P, Datta Gupta S, Ralhan R (2009) Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol 31(6):487-500. doi: 10.3233/CLO-2009-0507
30. Karray-Chouayekh S, Trifa F, Khabir A, Boujelbane N, Sellami-Boudawara T, Daoud J, Frikha M, Gargouri A, Mokdad-Gargouri R (2009) Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma. J Biomed Biotechnol 2009:369129. doi: 10.1155/2009/369129
31. Jing F, Jun L, Yong Z, Wang Y, Fei X, Zhang J, Hu L (2008) Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker. Oncology 75(1-2):60-66. doi: 10.1159/000155145
32. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353(17):1784-1792. doi: 10.1056/NEJMoa050518
33. Hayes DF, Isaacs C, Stearns V (2001) Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6(4):375-392
34. Ronneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, Naume B, Borresen-Dale AL, Tost J, Kristensen V (2011) Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol Oncol 5(1):61-76. doi: 10.1016/j.molonc.2010.11.004
35. Kennedy RD, Quinn JE, Johnston PG, Harkin DP (2002) BRCA1: mechanisms of inactivation and implications for management of patients. Lancet 360(9338):1007-1014. doi: 10.1016/S0140-6736(02)11087-7
36. Stefansson OA, Villanueva A, Vidal A, Marti L, Esteller M (2012) BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer. Epigenetics 7(11):1225-1229. doi: 10.4161/epi.22561
37. Krasteva ME, Bozhanov SS, Antov GG, Gospodinova ZI, Angelov SG (2012) Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status. Neoplasma 59(1):85-91
38. Jiang Y, Cui L, Chen WD, Shen SH, Ding LD (2012) The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data. PLoS One 7(5):e36780. doi: 10.1371/journal.pone.0036780
39. Hamilton MG, Roldan G, Magliocco A, McIntyre JB, Parney I, Easaw JC (2011) Determination of the methylation status of MGMT in different regions within glioblastoma multiforme. J Neurooncol 102(2):255-260. doi: 10.1007/s11060-010-0307-5
40. Wu TL, Zhang D, Chia JH, Tsao K, Sun CF, Wu JT (2002) Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 321(1-2):77-87
41. Kohler C, Barekati Z, Radpour R, Zhong XY (2011) Cell-free DNA in the circulation as a potential cancer biomarker. Anticancer Res 31(8):2623-2628
42. Ignatiadis M, Reinholz M (2011) Minimal residual disease and circulating tumor cells in breast cancer. Breast Cancer Res 13(5):222. doi: 10.1186/bcr2906
43. Dumitrescu RG (2012) Epigenetic markers of early tumor development. Methods Mol Biol 863:3-14. doi: 10.1007/978-1-61779-612-8-1
44. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(5181):2088-2090
45. Ben Gacem R, Hachana M, Ziadi S, Amara K, Ksia F, Mokni M, Trimeche M (2012) Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients. Cancer Epidemiol 36(2):190-197. doi: 10.1016/j.canep.2011.09.001
46. Nasir A, Shackelford RE, Anwar F, Yeatman TJ (2009) Genetic risk of breast cancer. Minerva Endocrinol 34(4):295-309